COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia by Roeker, Lindsey E., Knorr, David A., Thompson, Meghan C., Nivar, Mariely, Lebowitz, Sonia, Peters, Nicole, Deonarine, Isaac, Momotaj, Saddia, Sharan, Saumya, Chanlatte, Vanessa, Hampton, Bianca, Butala, Liana, Amato, Lindsay, Richford, Angela, Lunkenheimer, Jessica, Battiato, Kristen, Laudati, Carissa, Mato, Anthony R.

Get full text

Outcomes of COVID-19 in patients with CLL: a multicenter international experience by Mato, Anthony R., Roeker, Lindsey E., Lamanna, Nicole, Allan, John N., Leslie, Lori, Pagel, John M., Patel, Krish, Osterborg, Anders, Wojenski, Daniel, Kamdar, Manali, Huntington, Scott F., Davids, Matthew S., Brown, Jennifer R., Antic, Darko, Jacobs, Ryan, Ahn, Inhye E., Pu, Jeffrey, Isaac, Krista M., Barr, Paul M., Ujjani, Chaitra S., Geyer, Mark B., Berman, Ellin, Zelenetz, Andrew D., Malakhov, Nikita, Furman, Richard R., Koropsak, Michael, Bailey, Neil, Hanson, Lotta, Perini, Guilherme F., Ma, Shuo, Ryan, Christine E., Wiestner, Adrian, Portell, Craig A., Shadman, Mazyar, Chong, Elise A., Brander, Danielle M., Sundaram, Suchitra, Seddon, Amanda N., Seymour, Erlene, Patel, Meera, Martinez-Calle, Nicolas, Munir, Talha, Walewska, Renata, Broom, Angus, Walter, Harriet, El-Sharkawi, Dima, Parry, Helen, Wilson, Matthew R., Patten, Piers E.M., Hernández-Rivas, José-Ángel, Miras, Fatima, Fernández Escalada, Noemi, Ghione, Paola, Nabhan, Chadi, Lebowitz, Sonia, Bhavsar, Erica, López-Jiménez, Javier, Naya, Daniel, Garcia-Marco, Jose Antonio, Skånland, Sigrid S., Cordoba, Raul, Eyre, Toby A.

Get full text

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies by Roeker, Lindsey E., Eyre, Toby A., Thompson, Meghan C., Lamanna, Nicole, Coltoff, Alexander R., Davids, Matthew S., Baker, Peter O., Leslie, Lori, Rogers, Kerry A., Allan, John N., Cordoba, Raul, Lopez-Garcia, Alberto, Antic, Darko, Pagel, John M., Martinez-Calle, Nicolas, García-Marco, José Antonio, Hernández‐Rivas, Jose‐Ángel, Miras, Fatima, Coombs, Catherine C., Österborg, Anders, Hansson, Lotta, Seddon, Amanda N., López Jiménez, Javier, Wilson, Matthew R., El-Sharkawi, Dima, Wojenski, Daniel, Ma, Shuo, Munir, Talha, Valenciano, Susana, Seymour, Erlene, Barr, Paul M., Pu, Jeffrey, Patten, Piers E.M., Perini, Guilherme F., Huntington, Scott F., Parry, Helen, Sundaram, Suchitra, Skarbnik, Alan, Kamdar, Manali, Jacobs, Ryan, Walter, Harriet, Walewska, Renata, Broom, Angus, Lebowitz, Sonia, Isaac, Krista M., Portell, Craig A., Ahn, Inhye E., Ujjani, Chaitra S., Shadman, Mazyar, Skånland, Sigrid S., Chong, Elise A., Mato, Anthony R.

Get full text

A Phase 2 Study of Minimal Residual Disease (MRD)-Adapted Front Line Venetoclax and Obinutuzumab in Fit Patients with Chronic Lymphocytic Leukemia (CLL): Effect of Obinutuzumab on... by Roeker, Lindsey E., Zelenetz, Andrew D., Park, Jae H., Derkach, Andriy, Geyer, Mark Blaine, Islam, Prioty, Falchi, Lorenzo, Palomba, Maria Lia, Kumar, Anita, Salles, Gilles, Lue, Jennifer Kimberly, Goldberg, Aaron D., Fakhri, Bita, Coombs, Catherine C., Falco, Victoria, Panton, Gail, Tyznar, Dianna, Soni, Dhara, Nogan, Lauren, Lebowitz, Sonia, Blesie, Katherine, Shah, Monica, Court, Sarah, Jensen, Christopher E., Mato, Anthony R., Thompson, Meghan C.

Get full text

Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase 2 Study of an MRD-driven Approach by Roeker, Lindsey E., Feldman, Tatyana A., Soumerai, Jacob D., Falco, Victoria, Panton, Gail, Dorsey, Colleen, Zelenetz, Andrew D., Falchi, Lorenzo, Park, Jae H., Straus, David J., Velasquez, Camila Pena, Lebowitz, Sonia, Fox, Yehudit, Battiato, Kristen, Laudati, Carissa, Thompson, Meghan C., McCarthy, Elizabeth, Kdiry, Sabrina, Martignetti, Rosalba, Turpuseema, Teja, Purdom, Michelle, Paskalis, Dana, Miskin, Hari P., Sportelli, Peter, Leslie, Lori A., Mato, Anthony R.

Get full text

Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach by Roeker, Lindsey E, Feldman, Tatyana A, Soumerai, Jacob D, Falco, Victoria, Panton, Gail, Dorsey, Colleen, Zelenetz, Andrew D, Falchi, Lorenzo, Park, Jae H, Straus, David J, Pena Velasquez, Camila, Lebowitz, Sonia, Fox, Yehudit, Battiato, Kristen, Laudati, Carissa, Thompson, Meghan C, McCarthy, Elizabeth, Kdiry, Sabrina, Martignetti, Rosalba, Turpuseema, Teja, Purdom, Michelle, Paskalis, Dana, Miskin, Hari P, Sportelli, Peter, Leslie, Lori A, Mato, Anthony R

Get full text

A Phase 2 Study Evaluating the Addition of Ublituximab and Umbralisib (U2) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia (CLL): A Minimal Residual Disease (MRD)-Driven... by Roeker, Lindsey E., Leslie, Lori A., Soumerai, Jake D., Falco, Victoria, Panton, Gail, Zelenetz, Andrew D., Falchi, Lorenzo, Park, Jae H, Pena-Velasquez, Camila, Lebowitz, Sonia, Battiato, Kristen, Laudati, Carissa, Thompson, Meghan C., Straus, David J., Fox, Yehudit, McCarthy, Elizabeth, Kdiry, Sabrina, Martignetti, Rosalba, Miskin, Hari P., Sportelli, Peter, Mato, Anthony R.

Get full text

Worldwide Examination of Patients with CLL Hospitalized for COVID-19 by Roeker, Lindsey E, Scarfo, Lydia, Chatzikonstantinou, Thomas, Eyre, Toby A., Cordoba, Raul, Muntañola Prat, Ana, Leslie, Lori A., Koropsak, Michael, Allan, John N., Furman, Richard R., Patel, Krish, Motta, Marina, Bailey, Neil, Miras, Fatima, Lamanna, Nicole, Alonso, Rosalia, Osorio-Prendes, Santiago, Kamdar, Manali, Österborg, Anders, Hanson, Lotta, Baile, Mónica, Valenciano, Susana, Popov, Viola Maria, Eichhorst, Barbara, Lopez Jimenez, Javier, Romero, Pilar, Riaza Grau, Rosalía, Niemann, Carsten U, Perini, Guilherme Fleury, Yanez San Segundo, Lucrecia, Wilson, Matthew, Patten, Piers, Marasca, Roberto, Iyengar, Sunil, Seddon, Amanda, Torres, Ana, Ferrari, Angela, Cuéllar-García, Carolina, Itchaki, Gilad, Parry, Helen, Mateos-Mazón, Juan José, Ma, Shuo, Van Der Spek, Ellen, Seymour, Erlene K., Gimeno Vázquez, Eva, Mauro, Francesca Romana, Ruiz, Elena, Levin, Mark-David, Šimkovič, Martin, Špaček, Martin, Walewska, Renata, Sundaram, Suchitra, Wiestner, Adrian, Cuesta, Amalia, Broom, Angus, Kater, Arnon P., Ujjani, Chaitra S., Bron, Dominique, Vandenberghe, Elisabeth, Chong, Elise A., Lista, Enrico, García, Fiz Campoy, Ahn, Inhye, Malerba, Lara, Trentin, Livio, Farina, Lucia, Villalon, Lucia, Vidal, Maria Jesus, Sanchez, Maria Jose, Terol, Maria Jose, De Paolis, Maria Rosaria, Davids, Matthew S., Yassin, Mohamed A, Foglietta, Myriam, Sportoletti, Paolo, Barr, Paul M., Santiago, Raquel, Ruchlemer, Rosa, Huntington, Scott F., Herold, Tobias, Herishanu, Yair, Thompson, Meghan C., Lebowitz, Sonia, Ryan, Christine, Portell, Craig A., Rambaldi, Alessandro, Nabhan, Chadi, Rossi, Giuseppe, Garcia-Marco, Jose A., Coscia, Marta, Malakhov, Nikita, Fernandez-Escalada, Noemi, Coombs, Callie C., Schuster, Stephen J., Foà, Robin, Cuneo, Antonio, Bosch, Francesc, Stamatopoulos, Kostas, Mato, Anthony R., Patel, Meera

Get full text

Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer's Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial by Sultzer, David L., Davis, Sonia M., Tariot, Pierre N., Dagerman, Karen S., Lebowitz, Barry D., Lyketsos, Constantine G., Rosenheck, Robert A., Hsiao, John K., Lieberman, Jeffrey A., Schneider, Lon S.

Get full text

Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy by Passarelli, Chiara, Selvatici, Rita, Carrieri, Alberto, Di Raimo, Francesca Romana, Falzarano, Maria Sofia, Fortunato, Fernanda, Rossi, Rachele, Straub, Volker, Bushby, Katie, Reza, Mojgan, Zharaieva, Irina, D'Amico, Adele, Bertini, Enrico, Merlini, Luciano, Sabatelli, Patrizia, Borgiani, Paola, Novelli, Giuseppe, Messina, Sonia, Pane, Marika, Mercuri, Eugenio, Claustres, Mireille, Tuffery-Giraud, Sylvie, Aartsma-Rus, Annemieke, Spitali, Pietro, T'Hoen, Peter A C, Lochmüller, Hanns, Strandberg, Kristin, Al-Khalili, Cristina, Kotelnikova, Ekaterina, Lebowitz, Michael, Schwartz, Elena, Muntoni, Francesco, Scapoli, Chiara, Ferlini, Alessandra

Get full text

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer Disease Trial Methodology by Schneider, Lon S., Tariot, Pierre N., Lyketsos, Constantine G., Dagerman, Karen S., Davis, Kenneth L., Davis, Sonia, Hsiao, John K., Jeste, Dilip V., Katz, Ira R., Olin, Jason T., Pollock, Bruce G., Rabins, Peter V., Rosenheck, Robert A., Small, Gary W., Lebowitz, Barry, Lieberman, Jeffery A.

Get full text

Development of Diagnostic Criteria for Defining Sleep Disturbance in Alzheimer's Disease by Yesavage, Jerome A., Friedman, Leah, Ancoli-Israel, Sonia, Bliwise, Donald, Singer, Clifford, Vitiello, Michael V., Monjan, Andrew A., Lebowitz, Barry

Get full text

Dr. Lieberman and Colleagues Reply by LIEBERMAN, JEFFREY A., STROUP, T. SCOTT, McEVOY, JOSEPH P., SWARTZ, MARVIN S., ROSENHECK, ROBERT A., PERKINS, DIANA O., KEEFE, RICHARD S.E., DAVIS, SONIA M., DAVIS, CLARENCE E., HSIAO, JOHN, SEVERE, JOANNE, LEBOWITZ, BARRY D., the CATIE Investigators

Get full text